Dupuytren's Disease Management in the Post-collagenase Era: A Narrative Review
Cureus · 16.11.2026
DOI: 10.7759/cureus.119786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 16.11.2026. Verfasst von Rafael Sanjuan-Cervero und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Dupuytren's disease (DD) is a hereditary fibroproliferative disorder affecting the palmar fascia, leading to progressive finger contractures that may impair daily activities. Current treatment strategies aim to restore finger extension while minimizing functional loss and complications. Non-surgical options, such as percutaneous needle aponeurotomy and collagenase Clostridium histolyticum (CCH) injections, have been developed. CCH was withdrawn from the European market for commercial reasons in 2020, although it remains available in the United States and named-patient access may be possible in selected European countries, subject to local regulatory requirements and availability. Surgical intervention remains an important treatment option for established contractures, with limited fasciectomy being a commonly used approach. Recent trends favor minimally invasive techniques that aim to preserve healthy tissue, reduce recovery time, and minimize complications. This review evaluates non-surgical and surgical treatments for DD, exploring emerging trends in minimally invasive procedures and revisiting established surgical concepts. A literature search was conducted using PubMed, Web of Science, and Google Scholar, focusing on surgical and treatment options in the context of CCH withdrawal. Our findings underscore the importance of individualized treatment approaches that consider disease severity, functional impairment, patient characteristics, occupation, and preferences. As DD has no established definitive cure and recurrence remains a challenge, treatment selection should balance correction, durability, recovery, complications, and preservation of viable tissue. Although fasciectomy remains an important treatment option, less invasive approaches offer alternative strategies for selected patients. Further research is needed to improve patient selection and optimize treatment decisions. Understanding the advantages and limitations of the available techniques can support informed decision-making by patients and healthcare professionals.
Zitieren
APA
Sanjuan-Cervero, R., Lobo-Alcala, A., Sanjuan-Arago, A., Pena-Molina, F., & Montaner-Alonso, D. (2026). Dupuytren's Disease Management in the Post-collagenase Era: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.119786
Vancouver
Sanjuan-Cervero R, Lobo-Alcala A, Sanjuan-Arago A, Pena-Molina F, Montaner-Alonso D. Dupuytren's Disease Management in the Post-collagenase Era: A Narrative Review. Cureus. 2026. doi:10.7759/cureus.119786
BibTeX
@article{SanjuanCervero2026,
author = {Sanjuan-Cervero, Rafael and Lobo-Alcala, Ariadny and Sanjuan-Arago, Aurora and Pena-Molina, Fernando and Montaner-Alonso, Daniel},
title = {Dupuytren's Disease Management in the Post-collagenase Era: A Narrative Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119786}
}
EUVIMED